New Horizons in the Treatment of Systemic Sclerosis (2026)

Where is scleroderma research headed, and what does it mean for treatment? In this session, Dinesh Khanna, MD, MS (University of Michigan School of Medicine) takes a look at the advances poised to shape the future of scleroderma care and research, including T-cell therapies with exciting implications for SSc treatment.

This session was originally presented on June 11, 2026, as part of the 5th annual SRF Scleroderma Patient Forum.